1-3 of 3
Barbara Mucha
Close
Sort by
Journal Articles

Cladribine Added to Daunorubicin and Cytarabine Induction Regimen Prolongs Survival of Patients with Complex but Not Monosomal Karyotype Acute Myeloid Leukemia – Retrospective Analysis of Polish Adult Leukemia Group (PALG)

Agnieszka Wierzbowska, MD PhD, Ewa Wawrzyniak, PhD, Monika Siemieniuk-Rys, MSc, Aleksandra Kotkowska, PhD, Agnieszka Pluta, MD PhD, Tadeusz Robak, MD, Anna Jaskowiec, MSc, Ewa Duszenko, MSc, Marta Szarawarska, MSc, Justyna Rybka, MD PhD, Jadwiga Holojda, MD, Sebastian Grosicki, MD, Barbara Pienkowska-Grela, PhD, Renata Woroniecka, PhD, Anna Ejduk, MDPhD, Marzena Watek, MD, Malgorzata Wach, MDPhD, Barbara Mucha, PhD, Katarzyna Skonieczka, PhD, Maria Czyzewska, MD, Anna Jachalska, MD, Agnieszka Klonowska, MSc, Mariola Iliszko, PhD, Wanda Knopinska-Posluszny, Malgorzata Jarmuz-Szymczak, PhD, Anna Przybylowicz-Chalecka, MSc, Lidia Gil, MD PhD, Agnieszka Kopacz, MD, Jerzy Holowiecki, MD PhD, Olga Haus, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2347.
https://doi.org/10.1182/blood.V124.21.2347.2347
Published: 2014
Journal Articles

Is Type of Monosomy (Total or Partial) Crucial for Prognostic Value of Monosomal Karyotype in AML Patients? – Preliminary Results of Retrospective Polish Adult Leukemia Group (PALG) Study,

Ewa Wawrzyniak, PhD, Agnieszka Wierzbowska, MD, PhD, Kotkowsa Aleksandra, MSc, Monika Siemieniuk-Rys, MSc, Joanna Kosny, student, Aleksandra Golos, MD, Agnieszka Pluta, MD, PhD, Tadeusz Robak, MD, PhD, Wanda Knopinska-Posluszny, MD, PhD, Agnieszka Klonowska, MSc, Mariola Iliszko, PhD, Andrzej Hellmann, MD, PhD, Renata Woroniecka, PhD, Barbara Pienkowska-Grela, PhD, Anna Ejduk, MD, PhD, Krzysztof Warzocha, MD, Malgorzata Wach, MD, PhD, Anna Dmoszynska, Ewa Duszenko, MSc, Anna Jaskowiec, MSc, Malgorzata Jakobczyk, MSc, Barbara Mucha, PhD, Sebastian Grosicki, MD, Jerzy Holowiecki, MD, PhD, Olga Haus, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3537.
https://doi.org/10.1182/blood.V118.21.3537.3537
Published: 2011
Journal Articles

Significance of BAALC , MN 1, ERG , CEBP a Gene Expression as New Prognostic Factors, in the Context of Other Molecular Markers in Intermediate Risk AML Group According to Cytogenetics, Including Patients Younger Than 60 Years

Marta Antonina Libura, MD, PhD, Beata Piatkowska-Jakubas, Olga Haus, Izabela Florek, Bozena Jazwiec, PhD, Krystyna Soszynska, PhD, Zoriana Salamanchuk, PhD, Malgorzata Jakobczyk, Szymon Fornagiel, Tomasz Sacha, Marek Kielbinski, Kazimierz Kuliczkowski, Ewa Duszenko, Anna Jaskowiec, Barbara Mucha, Katarzyna Skonieczna, Aleksander Skotnicki
Journal: Blood
Blood (2008) 112 (11): 4855.
https://doi.org/10.1182/blood.V112.11.4855.4855
Published: 2008